2014
Plasminogen activation is a ubiquitous source of fibrinolytic and proteolytic activity. Besides its role in prevention of thrombosis, plasminogen is (…)
Consulter 
2014
Worldwide, stroke is the leading cause of disability in the aging population. Neuroinflammation is a common feature of acute stroke (…)
Consulter
2015
Consulter
2015
Despite the effectiveness of recombinant tissue-type plasminogen activator (r-tPA) during the acute phase of ischemic stroke, the therapy remains limited (…)
Consulter
2015
Factor VII activating protease (FSAP) is a circulating protease with a putative role in hemostasis, remodeling and inflammation. A polymorphism (…)
Consulter
2015
Tissue-type plasminogen activator (tPA) is the only acute treatment for ischemic stroke. Unfortunately, the benefit of tPA-driven thrombolysis is not (…)
Consulter
